Protecting Your Pathology: Cybersecurity for Digital Workflows
Digital pathology opens up new cybersecurity risks for labs—but simple steps can mitigate those risks and increase digital resilience
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
Digital pathology opens up new cybersecurity risks for labs—but simple steps can mitigate those risks and increase digital resilience
Depending on the reporting laboratory, patients who undergo whole exome sequencing may receive false negatives or incomplete test results. That is the finding of a new study published in Clinical Chemistry
On Dec. 30, 2019, the U.S. Food and Drug Administration (FDA) published a final order exempting dozens of Class I and Class II medical devices that previously required 510(k) submission from 510(k) premarket review